CIA
AMED

CSat Investment Advisory’s Amedisys AMED Stock Holding History

CSat Investment Advisory’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-155
Closed -$37K – 541
2020
Q3 		$37K Buy
155
+22
+17% +$5K ﹤0.01% 714
2020
Q2 		$26K Buy
133
+26
+24% +$4.85K ﹤0.01% 769
2020
Q1 		$20K Buy
107
+21
+24% +$3.74K ﹤0.01% 719
2019
Q4 		$14K Buy
86
+10
+13% +$1.49K ﹤0.01% 885
2019
Q3 		$10K Buy
76
+10
+15% +$1.3K ﹤0.01% 912
2019
Q2 		$8K Buy
+66
New +$7.83K ﹤0.01% 934

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CSat Investment Advisory's AMED Position: Q4 2020 in Review

CSat Investment Advisory sold out of Amedisys (AMED) in Q4 2020, closing a stake of 155 shares — an estimated $37K sold.

CSat Investment Advisory first reported a position in AMED in Q2 2019 and held it in 6 quarters. The position peaked at $37K in Q3 2020. 397 funds tracked by Wall St. Rank hold AMED as of Q4 2020.

  • CSat Investment Advisory reported no remaining Amedisys position as of Q4 2020 after selling out during the quarter.
  • CSat Investment Advisory sold 155 Amedisys shares in Q4 2020, an estimated $37K.
  • CSat Investment Advisory first reported a position in Amedisys in Q2 2019 and held it in 6 quarters.
  • CSat Investment Advisory's Amedisys position peaked at $37K in Q3 2020.
  • 397 funds tracked by Wall St. Rank held Amedisys as of Q4 2020.

Based on CSat Investment Advisory's 13F filing for Q4 2020, filed 12 Feb 2021.